Ameriprise’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-89,771
| Closed | -$9.15M | – | 4000 |
|
|
2023
Q2 | $9.15M | Buy |
89,771
+84,396
| +1,570% | +$8.61M | ﹤0.01% | 1849 |
|
|
2023
Q1 | $489K | Sell |
5,375
-3,641
| -40% | -$331K | ﹤0.01% | 3436 |
|
|
2022
Q4 | $343K | Buy |
9,016
+826
| +10% | +$31.4K | ﹤0.01% | 3538 |
|
|
2022
Q3 | $205K | Buy |
+8,190
| New | +$205K | ﹤0.01% | 3693 |
|
|
2021
Q4 | – | Sell |
-3,015
| Closed | -$304K | – | 4066 |
|
|
2021
Q3 | $304K | Sell |
3,015
-100,211
| -97% | -$10.1M | ﹤0.01% | 3565 |
|
|
2021
Q2 | $14.6M | Buy |
103,226
+492
| +0.5% | +$69.6K | ﹤0.01% | 1600 |
|
|
2021
Q1 | $10.2M | Buy |
102,734
+23,281
| +29% | +$2.32M | ﹤0.01% | 1865 |
|
|
2020
Q4 | $9.82M | Buy |
79,453
+18,978
| +31% | +$2.35M | ﹤0.01% | 1769 |
|
|
2020
Q3 | $5.89M | Sell |
60,475
-180,393
| -75% | -$17.6M | ﹤0.01% | 1959 |
|
|
2020
Q2 | $37.6M | Buy |
240,868
+25,897
| +12% | +$4.04M | 0.02% | 728 |
|
|
2020
Q1 | $31M | Buy |
214,971
+106,305
| +98% | +$15.3M | 0.02% | 723 |
|
|
2019
Q4 | $22.2M | Buy |
108,666
+23,255
| +27% | +$4.75M | 0.01% | 1113 |
|
|
2019
Q3 | $6.86M | Sell |
85,411
-45,475
| -35% | -$3.65M | ﹤0.01% | 1983 |
|
|
2019
Q2 | $12.3M | Buy |
130,886
+10,713
| +9% | +$1.01M | 0.01% | 1565 |
|
|
2019
Q1 | $10.3M | Sell |
120,173
-60,904
| -34% | -$5.21M | ﹤0.01% | 1683 |
|
|
2018
Q4 | $10.2M | Sell |
181,077
-52,551
| -22% | -$2.95M | 0.01% | 1591 |
|
|
2018
Q3 | $19.1M | Sell |
233,628
-173,095
| -43% | -$14.2M | 0.01% | 1342 |
|
|
2018
Q2 | $14.2M | Buy |
406,723
+375,446
| +1,200% | +$13.1M | 0.01% | 1442 |
|
|
2018
Q1 | $641K | Sell |
31,277
-322
| -1% | -$6.6K | ﹤0.01% | 3133 |
|
|
2017
Q4 | $895K | Sell |
31,599
-444
| -1% | -$12.6K | ﹤0.01% | 3019 |
|
|
2017
Q3 | $997K | Buy |
+32,043
| New | +$997K | ﹤0.01% | 2963 |
|